Novacyt unveils new coronavirus test

Published On 2020-02-02 04:00 GMT   |   Update On 2020-02-02 04:00 GMT

Novacyt said its Primerdesign coronavirus test could detect the 2019 strain of the virus, adding it believed this would differentiate it from other current tests which it said were less specific.

New Delhi: Healthcare company Novacyt said on Friday it had launched a new molecular test for the coronavirus currently afflicting China and other parts of the world.

The company said its Primerdesign coronavirus test could detect the 2019 strain of the virus, adding it believed this would differentiate it from other current tests which it said were less specific.

Also Read: Gilead Offers To Test Ebola Drug Remdesivir As New Coronavirus Treatment In China

"Over the last few days, we have seen significant early demand for our 'genesig 2019-nCoV' test from over 10 countries," CEO Graham Mullis said in a statement

"We believe our assay is the first European test to be made available and will be introduced this weekend at the Medlab Expo in the Middle East," added Mullis.

More than 200 people have been killed by the virus, with some 9,820 people infected around the world.

The virus is believed to have originated in a food market illegally selling wildlife in Wuhan. About 60 million people in Hubei province are living under virtual lockdown.

Also Read: Beijing Drug Store Fined Whooping $434,530 For Hiking Price Of Masks 

Tags:    
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News